Kangmei Pharma | 600518 - Ebitda



Kangmei Pharma reported -3262057.35 in EBITDA for its fiscal quarter ending in September of 2024.


Ebitda Change Date
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
Avita Medical AUD -9863000 3.95M Dec/2024
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -34828000 2.99M Jun/2025
Genomma Lab Internacional MXN 1.02B 116.02M Mar/2025
Hypermarcas BRL 765.92M 914.42M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
IQVIA Holdings USD 910M 112M Jun/2025
Jiangsu Hengrui 2.98B 890.87M Jun/2025
Kangmei Pharma -3262057.35 15.91M Sep/2024
Moderna USD -760000000 164M Jun/2025
Organon & Co USD 522M 114M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Sh Fosun Pharma 1.69B 17.13M Jun/2025
Tectonic Therapeutic USD -13483000 5.73M Dec/2024
Viatris USD 1.08B 218.1M Jun/2025
WuXi AppTec 5.71B 1.36B Jun/2025
Xeris Pharmaceuticals USD 8.59M 2.87M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 1.19B 829.65M Mar/2025